Krisani Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 18.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 17.83 Cr
as on 04-07-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2018)
- Profit 97.22%
(FY 2018)
- Ebitda 56.99%
(FY 2018)
- Net Worth -0.32%
(FY 2018)
- Total Assets 2.01%
(FY 2018)
About Krisani Bio Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 18.00 Cr and a paid-up capital of Rs 17.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sarada Kalidindi and Krishnam Kalidindi serve as directors at the Company.
- CIN/LLPIN
U73200TG2009PTC065750
- Company No.
065750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2009
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Krisani Bio Sciences Private Limited offer?
Krisani Bio Sciences Private Limited offers a wide range of products and services, including Dinnerware and Serving Utensils, Serving Plate.
Who are the key members and board of directors at Krisani Bio Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarada Kalidindi  | Director | 02-Apr-2014 | Current |
| Krishnam Kalidindi | Director | 10-Nov-2009 | Current |
Financial Performance of Krisani Bio Sciences.
Krisani Bio Sciences Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 97.22% increase in profit. The company's net worth dipped by a decrease of 0.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krisani Bio Sciences?
In 2018, Krisani Bio Sciences had a promoter holding of 44.46% and a public holding of 55.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innovision Life Sciences Private LimitedActive 15 years 4 monthsSarada Kalidindi and Krishnam Kalidindi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Krisani Bio Sciences?
Unlock and access historical data on people associated with Krisani Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krisani Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krisani Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
